Wolfe Research analyst Peter Supino downgrades T-Mobile US (NASDAQ:TMUS) from Outperform to Peer Perform.
Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.